{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-045012","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2024-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.350497+00:00","generated_at":"2026-05-30T06:44:06.682282+00:00","sec_items":["1.02","2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Medifast Q3 2024 revenue down 40.6% to $140.2M; EPS $0.10; guides Q4 revenue $100-120M","bullets":["Revenue $140.2M, down 40.6% YoY; net income $1.1M ($0.10 diluted EPS); adjusted EPS $0.35.","Active earning OPTAVIA coaches fell 36.3% to 30,000; average revenue per coach $4,672 (down from $5,008).","Cash $170M, no debt; credit facility canceled, saving ~$500k annual commitment fees.","Q4 2024 guidance: revenue $100-120M, diluted loss per share $0.10-$0.65."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-045012","json":"https://secwatch.observer/filing/0001628280-24-045012.json","markdown":"https://secwatch.observer/filing/0001628280-24-045012.md","text":"https://secwatch.observer/filing/0001628280-24-045012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000162828024045012/0001628280-24-045012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000162828024045012/med-20241030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:44:06.682282+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}